• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON UNSPECIFIED BD ULTRAFINE NANO PEN NEEDLE; HYPODERMIC SINGLE LUMEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON UNSPECIFIED BD ULTRAFINE NANO PEN NEEDLE; HYPODERMIC SINGLE LUMEN NEEDLE Back to Search Results
Catalog Number UNKNOWN
Device Problem Failure to Deliver (2338)
Patient Problems Hyperglycemia (1905); Skin Inflammation/ Irritation (4545)
Event Date 02/15/2022
Event Type  malfunction  
Event Description
It was reported that the unspecified bd ultrafine nano pen needle experienced a case of being unable to deliver insulin, and a case of not functioning.The following information was provided by the initial reporter: after starting insulin therapy, his pen got locked up, he was not able to get all medication out of it.It stopped working.
 
Manufacturer Narrative
Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident and without this information we are unable to determine where the device was manufactured.Therefore, bd corporate headquarters in (b)(4) has been listed and the (b)(4) fda registration number has been used for the manufacture report number.Date of birth: only the patient's age was provided, therefore a default date of birth has been listed.Device expiration date: unknown.Date of event: unknown.The date received by manufacturer has been used for this field.Device manufacture date: unknown.
 
Manufacturer Narrative
Investigation: no samples (including photos) were returned therefore the complaint could not be confirmed and the root cause is undetermined.Due to the batch being unknown, no dhr review can be completed.
 
Event Description
It was reported that the unspecified bd ultrafine nano pen needle experienced a case of being unable to deliver insulin, and a case of not functioning.The following information was provided by the initial reporter: after starting insulin therapy, his pen got locked up, he was not able to get all medication out of it.It stopped working.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNSPECIFIED BD ULTRAFINE NANO PEN NEEDLE
Type of Device
HYPODERMIC SINGLE LUMEN NEEDLE
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13620824
MDR Text Key287597368
Report Number2243072-2022-00291
Device Sequence Number1
Product Code FMI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/15/2022
Initial Date FDA Received02/28/2022
Supplement Dates Manufacturer Received03/03/2022
Supplement Dates FDA Received03/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age64 YR
Patient SexMale
-
-